BDBM50269164 CHEMBL4071371

SMILES: CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1)C(=O)NC(C)(C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O

InChI Key: InChIKey=WRGBEYNJXNFSHM-QADYPTBRSA-N

Data: 1 IC50  1 EC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50269164   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Neuropeptide Y receptor type 2 (Homo sapiens (Human))	BDBM50269164 (CHEMBL4071371) Show SMILES CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1)C(=O)NC(C)(C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O |r| Show InChI InChI=1S/C81H134N26O16/c1-45(2)37-57(75(121)107-81(4,5)77(123)106-64(46(3)108)76(122)99-54(31-20-36-94-80(89)90)67(113)98-55(32-33-62(82)109)70(116)97-53(30-19-35-93-79(87)88)68(114)100-56(65(84)111)38-47-21-10-6-11-22-47)101-74(120)61(42-63(83)110)105-72(118)59(40-49-25-14-8-15-26-49)102-71(117)58(39-48-23-12-7-13-24-48)103-73(119)60(41-51-43-91-44-95-51)104-69(115)52(29-18-34-92-78(85)86)96-66(112)50-27-16-9-17-28-50/h9,16-17,27-28,43-49,52-61,64,108H,6-8,10-15,18-26,29-42H2,1-5H3,(H2,82,109)(H2,83,110)(H2,84,111)(H,91,95)(H,96,112)(H,97,116)(H,98,113)(H,99,122)(H,100,114)(H,101,120)(H,102,117)(H,103,119)(H,104,115)(H,105,118)(H,106,123)(H,107,121)(H4,85,86,92)(H4,87,88,93)(H4,89,90,94)/t46-,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,64+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	7.40	n/a	n/a	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Company, Ltd. Curated by ChEMBL					Assay Description Displacement of [125I]peptide YY from human Y2 receptor expressed in CHO cell membranes after 60 mins by TopCount scintillation counting analysis				Bioorg Med Chem Lett 27: 3829-3832 (2017) Article DOI: 10.1016/j.bmcl.2017.06.055 BindingDB Entry DOI: 10.7270/Q2MK6GC2
					More data for this Ligand-Target Pair
Neuropeptide Y receptor type 2 (Homo sapiens (Human))	BDBM50269164 (CHEMBL4071371) Show SMILES CC(C)C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1CCCCC1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccccc1)C(=O)NC(C)(C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1CCCCC1)C(N)=O |r| Show InChI InChI=1S/C81H134N26O16/c1-45(2)37-57(75(121)107-81(4,5)77(123)106-64(46(3)108)76(122)99-54(31-20-36-94-80(89)90)67(113)98-55(32-33-62(82)109)70(116)97-53(30-19-35-93-79(87)88)68(114)100-56(65(84)111)38-47-21-10-6-11-22-47)101-74(120)61(42-63(83)110)105-72(118)59(40-49-25-14-8-15-26-49)102-71(117)58(39-48-23-12-7-13-24-48)103-73(119)60(41-51-43-91-44-95-51)104-69(115)52(29-18-34-92-78(85)86)96-66(112)50-27-16-9-17-28-50/h9,16-17,27-28,43-49,52-61,64,108H,6-8,10-15,18-26,29-42H2,1-5H3,(H2,82,109)(H2,83,110)(H2,84,111)(H,91,95)(H,96,112)(H,97,116)(H,98,113)(H,99,122)(H,100,114)(H,101,120)(H,102,117)(H,103,119)(H,104,115)(H,105,118)(H,106,123)(H,107,121)(H4,85,86,92)(H4,87,88,93)(H4,89,90,94)/t46-,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,64+/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	2	n/a	n/a	n/a	n/a
Takeda Pharmaceutical Company, Ltd. Curated by ChEMBL					Assay Description Agonist activity at human Y2 receptor expressed in CHO cell membranes after 120 mins by [35S]GTPgammaS binding assay				Bioorg Med Chem Lett 27: 3829-3832 (2017) Article DOI: 10.1016/j.bmcl.2017.06.055 BindingDB Entry DOI: 10.7270/Q2MK6GC2
					More data for this Ligand-Target Pair